DMC Biotechnologies, a leading U.S.-based biomanufacturer, launched fermented myo-inositol. This next-generation ingredient – the company says – is now available for health-focused brands and formulators seeking high-quality, naturally produced, sustainable solutions, with improved supply resilience.
IL BIOECONOMISTA 